Zhen-Nan Ye

Zhen-Nan Ye

Auto-generated profile, based on publicly available information

Zhen-Nan Ye

Department of Neurosurgery, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province 510260, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2018 in Behavioural Neurology
Verified
Journal Article
Open access
PDF file
LWLing-Yun Wu
Ling-Yun Wu
ZYZhen-Nan Ye
Zhen-Nan Ye
ZZZong Zhuang
Zong Zhuang
YGYongyue Gao
Yongyue Gao
CTChao Tang
Chao Tang
JSJixin Shi
Jixin Shi
Inflammatory injury and neuronal apoptosis participate in the period of early brain injury (EBI) after subarachnoid hemorrhage (SAH). Suppression of inflammation has recently been shown to reduce neuronal death and neurobehavioral dysfunction post SAH. Biochanin A (BCA), a natural bioactive isoflavonoid, has been confirmed to emerge the anti-inflammatory pharmacological function. This original study was aimed at evaluating and identifying the neuroprotective role of BCA and the underlying molecular mechanism in an experimental Sprague-Dawley rat SAH model. Neurobehavioral function was evaluated via the modified water maze test and modified Garcia neurologic score system. Thus, we confirmed that BCA markedly decreased the activated level of TLRs/TIRAP/MyD88/NF-κB pathway and the production of cytokines. BCA also significantly ameliorated neuronal apoptosis which correlated with the improvement of neurobehavioral dysfunction post SAH. These results indicated that BCA may provide neuroprotection against EBI through the inhibition of inflammatory injury and neuronal apoptosis partially via the TLRs/TIRAP/MyD88/NF-κB signal pathway.

1 October 2016 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
QCQiang Chen
Qiang Chen
ZYZhen-Nan Ye
Zhen-Nan Ye
JLJing-Peng Liu
Jing-Peng Liu
ZZZi-Huan Zhang
Zi-Huan Zhang
CZChen-Hui Zhou
Chen-Hui Zhou
CHChun-Hua Hang
Chun-Hua Hang

1 January 2017 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SLShaoxue Li
Shaoxue Li
XXXiaolan Xiao
Xiaolan Xiao
XNXiaojia Ni
Xiaojia Ni
ZYZhennan Ye
Zhennan Ye
JZJunjie Zhao
Junjie Zhao
CHChun-Hua Hang
Chun-Hua Hang
This study was to test the hypothesis that tetramethylpyrazine (TMP) protected against early brain injury after subarachnoid hemorrhage (SAH) by affecting the mitochondrial‐dependent caspase‐3 apoptotic pathway. TMP was administrated after the rats’ prechiasmatic SAH mode. Animal neurobehavioral functions were assessed and the mitochondrial morphology, mitochondrial and cytoplasmic calcium, and mitochondrial membrane potential changes (Δψm) of the brain tissues were measured. The expressions of cytoplasmic cytochrome c (cyt c), second mitochondria‐derived activator of caspases (Smac), and cleaved caspase‐3 B‐cell lymphoma 2 (bcl‐2) in cells were determined and cellular apoptosis was detected. The treatment of TMP resulted in less apoptotic cells and milder mitochondrial injury and potentially performed better in the neurobehavioral outcome compared to those with saline. Also, TMP ameliorated calcium overload in mitochondria and cytoplasm and alleviated the decrease of Δψm. In addition, TMP inhibited the expression of cytoplasmic cyt c, Smac, and cleaved caspase‐3, yet it upregulated the expression of bcl‐2. These findings suggest that TMP exerts an antiapoptosis property in the SAH rat model and this is probably mediated by the caspase‐3 apoptotic pathway triggered by mitochondrial calcium overload. The finding offers a new therapeutic candidate for early brain injury after SAH.